期刊文献+

小肽免疫抑制剂的活性研究 被引量:1

The Biological Activities of the Small Peptide Immunosuppressant
下载PDF
导出
摘要 用标准的 Fmoc保护氨基酸 Nα 氨基的固相法合成了 6肽 Ac-XCSSXX-NH2 (— CSS—为保守序列 ,该设计合成的 6肽是从若干单克隆中挑选出与 IL-2结合力最高的 ) ,经 HPLC纯化 ,并通过 MS检测 .分别以Con A诱导的淋巴细胞转化实验和 IL-2诱导的淋巴母细胞转化实验为体外模型 ,以大鼠肝脏移植为体内模型 ,观察小肽对移植排斥的影响 .在 Con A诱导的淋转实验中 ,加入小肽 ( 2 5 0~ 31 .2 5 μg/m L)对淋转反应有明显的抑制作用 ( P 0 .0 1 ) ,在终浓度为 31 .2 5μg/m L时 ,抑制率达到最高 .IL-2诱导的淋转实验得到与上述相符的结果 ,从而进一步表明 :小肽是通过抑制 IL-2和 IL-2 R的结合从而实现其免疫抑制作用的 .在大鼠肝脏移植模型中 :给术后大鼠注射小肽共 5 d( 1 0 mg/kg) According to the previous studies, in which we used a monoclonal antibody 5G1 that is specific for the human IL 2 receptor α chain to screen a random hexa peptide library and obtained the phage clone which has good combinative activities studied by Elisa, the consensus sequence motif C-S-S was revealed by DNA sequencing, the peptide Ac XCSSXX NH 2 was synthesized, then purified by HPLC and confirmed by MS. To investigate the biological activities of the hexa peptide, we constructed the vitro model of the lymphocyte proliferation experiment(LPE) induced by ConA and IL 2 and the vivo model with liver transplanting of rat. In the LPE induced by ConA, the addition of hexa peptide(250-31 25 μg/mL) had a significant inhibitory effect to LPE( P 0 01). The minimal inhibitory mass concentration is 31 25 μg/mL, with the inhibitory rate of 78.16%. In the LPE induced by IL 2, we obtained the same result as the LPE induced by ConA. So we can say that the peptide realizes its immuno suppresive effect by blocking the combination of IL 2 and IL 2R. In the liver transplanting model of rat, the injection of the peptide to the operated rat in five days would prolong the survival time of the rat.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2001年第10期1744-1747,共4页 Chemical Journal of Chinese Universities
基金 国家自然科学基金 (批准号 :30 0 70 892 )资助
关键词 小肽 免疫抑制剂 噬菌体肽库 器官移植 白细胞介素-2受体 α链 生物活性 白细胞介素2 移植排斥反应 治疗 Hexa peptide Immunosuppressant Phage peptide library Liver transplant Interleukin 2 receptor α chain
  • 相关文献

参考文献1

二级参考文献2

  • 1Yu J,Methods Enzymology,1996年,267卷,3页 被引量:1
  • 2Jain J,Current Opinion Immunology,1995年,7卷,333页 被引量:1

共引文献3

同被引文献40

  • 1Adriano M. C. Pimenta,Maria Elena De Lima. Small peptides, big world: biotechnological potential in neglected bioactive peptides from arthropod venoms[ J]. Peptide Sci ,2005, ( 11 ) : 670 被引量:1
  • 2Erb K, Klipping C, Duijkers I, et al. Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women [ J ]. Fertility and Sterility, 2001, 75(2) :316 被引量:1
  • 3Lizio R, Klenner T, Borchard G, et al. Systemic delivery of the GnRH antagonist cetrorelix by intratracheal instillation in anesthetized rats [J]. European Journal of Pharmaceutical Sciences , 2000, (9) :253 被引量:1
  • 4Shekman LW, David T, Baughman SA, et al. Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer [ J ]. Clinical pharmacology and therapeutics ,2003,73 (4) :304 被引量:1
  • 5Mouedden ME, Vandermeeren M, Meert T, et al. Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyoidl peptides[ J]. Journal of Neuroscience Methods ,2005,145:97 被引量:1
  • 6Smith CJ, Gali H, Gary L. et al. ^177 Lu-Radioehemieal investigations of ^177 Lu-DOTA-8-Aoc-BBN [ 7-14] NH2 : an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells [ J ]. Nuclear Medicine and Biology ,2003,30 : 101 被引量:1
  • 7Achilefu S, Sfinivasan A, Michelle A, et al. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceutical and molecular beacons to tumors [ J ]. J. Med. Chem ,2003,46:3403 被引量:1
  • 8Eva M. Molina-Trinidad, Consuelo Arteaga de Murphy, Guillermina Ferro-Flores, et al. Radiopharmacokinetic and dosimetric parameters of ^188Re-lanreotidein athymic mice with induced human cancer tumors [ J ]. International Journal of Pharmaceutics , 2006,310:125 被引量:1
  • 9Chen XY, Park R, Anthony H, et al. Pharmacokinetics and tumor retention of ^125 I-labeled RGD peptide are improved by PEGylation [ J]. Nuclear Medicine and Biology ,2004,31:11 被引量:1
  • 10Chen XY,Parka R,Anthony H, et al. ^18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis [ J ]. Nuclear Medicine and Biology ,2004,31 : 179 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部